Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity

References

• Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, . Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 2004;364: 141–8.
   Google Scholar
• Janssens S, Dubois C, Bogaert J, Theunissen K, Deroose C, Desmet W, . Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. Lancet 2006;367:113–21.
   PubMedGoogle Scholar
• Lunde K, Solheim S, Aakhus S, Arnesen H, Moum T, Abdelnoor M, . Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006;355:1199–209.
   PubMed Web of Science ®Google Scholar
• SchächingerV, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Hölschermann H, . Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210–21.
   PubMed Web of Science ®Google Scholar
• Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Mesquita CT, . Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 2003;107:2294–302.
   PubMed Web of Science ®Google Scholar
• Hendrikx M, Hensen K, Clijsters C, Jongen H, Koninckx R, Bijnens E, . Recovery of regional but not global contrac-tile function by the direct intramyocardial autologous bone marrow transplantation: results from a randomized controlled clinical trial. Circulation 2006;114:101–7.
   PubMed Web of Science ®Google Scholar
• Zeng L, Hu Q, Wang X, Mansoor A, Lee J, Feygin J, . Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in heart with postinfarction left ventricular remodeling. Circulation 2007;115:1866–75.
   PubMed Web of Science ®Google Scholar
• Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, . Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 2003;107:1024–32.
   PubMed Web of Science ®Google Scholar
• Gruh I, Beilner J, Blomer U, Schmiedl A, Schmidt-Richter I, Kruse ML, . No evidence of transdifferentiation of human endothelial progenitor cells into cardiomyocytes after coculture with neonatal rat cardiomyocytes. Circulation 2006;113:1326–34.
   PubMed Web of Science ®Google Scholar
• Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubert M, . Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664–8.
   PubMed Web of Science ®Google Scholar
• Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004;428:668–73.
   PubMed Web of Science ®Google Scholar
• Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, . Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 2005;96:127–37.
   PubMed Web of Science ®Google Scholar
• Yoon BS, Yoon SJ, Lee JE, You S, Lee HT, Yoon HS. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 2006;74:149 59.
   PubMed Web of Science ®Google Scholar
• Xu W, Zhang X, Qian H, Zhu W, Sun X, Hu J, . Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro . Exp Biol Med (Maywood) 2004;229:623–31.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, . Progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001;89:e1–e7.
   PubMed Web of Science ®Google Scholar
• Grinnemo K, Broberg-Månsson A, Leblanc K, Corbascio M, Wärdell E, Siddiqui A, . Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel. Ann Med 2006;38:144–53.
   PubMed Web of Science ®Google Scholar
• Rangappa S, Entwistle JW, Zechsler AS, Kresh JY. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J Thorac Cardiovasc Surg 2003;126:124–32.
   PubMed Web of Science ®Google Scholar
• Li X, Yu X, Lin Q, Deng C, Shan Z, Yang M, . Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J Moll Cell Cardiol 2007;42:295–303.
   PubMedGoogle Scholar
• Kubo H, Jaleel N, Kumaraperli A, Berretta RM, Bratinov G, Shan X, . Increased cardiac myocytes progenitors in failing human hearts. Circulation 2008;118:649–57.
   PubMed Web of Science ®Google Scholar
• Daniëls A, Koninckx R, Steels P, Hendrikx M, Rummens J-L, Hensen K. Cardiac stem cells: a new potential tool for cardiac repair? Acta Clin Bel 2009;64(abstr):76.
   Google Scholar
• Ding B, Liu CJ, Huang Y, Hickey RP, Yu J, Kong W, . p204 is required for the differentiation of P19 murine embryonal carcinoma cells into beating cardiac myocytes: its expression is activated by the cardiac Gata-4, Nkx2. 5, and Tbx5 proteins. J Biol Chem 2006;281:14882–92.
   PubMedGoogle Scholar
• Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 2002;99:9550–5.
   PubMed Web of Science ®Google Scholar
• Antonitsis P, Ioannidou-Papagiannaki E, Kaidoglou A, Papakonstantinou C. In vitro cardiomyogenic differentiation of adult human bone marrow mesenchymal stem cells. The role of 5-azacytidine. Interact Cardiovasc Thorac Surg 2007;6:593–7.
   PubMedGoogle Scholar
• Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, Pan J, . Cardiomyocytes can be generated from marrow stromal cells in vitro . J Clin Invest 1999;102:697–705.
   Google Scholar
• Hattan N, Kawaguchi H, Ando K, Kuwabara E, Fujita J, Murata M, . Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intercardiac grafts in mice. Cardiovasc Res 2005;65:334–44.
   PubMed Web of Science ®Google Scholar
• Fukuhara S, Tomita S, Yamashiro S, Morisaki T, Yutani C, Kitamura S, . Direct cell–cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro . J Thorac Cardiol Surg 2003;125:1470–80.
   PubMed Web of Science ®Google Scholar
• Yoon J, Shim WJ, Ro YM, Lim DS. Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Ann Hematol 2005;84:715–21.
   PubMedGoogle Scholar
• Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, . Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004;95:911–21.
   PubMed Web of Science ®Google Scholar
• Pijnappels D, Schalij M, Ramkisoensing A, van Tuyn J, de Vries A, van der Laarse A, . Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ Res 2008;103:167–76.
   PubMed Web of Science ®Google Scholar
• Rose RA, Jiang H, Wang X, Helke S, Tsoporin JN, Gong N, . Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal pheno-type and do not become functional cardiomyocytes in vitro . Stem Cells 2008;26:2884–92.
   PubMed Web of Science ®Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002;105:93–8.
   PubMed Web of Science ®Google Scholar
• Grauss RW, Winter EM, van Tuyn J, Pijnappels DA, Vicente Steijn R, Hogers B, . Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007;293:H2438–47.
   Web of Science ®Google Scholar
• Wang X, Takagawa J, Saini S, Su R, Sievers R, Clifford B, . Donor aging or myocardial infarction impairs bone marrow cell therapy for the infarcted heart. Circulation 2008;118(abstr):S322.
   Google Scholar
• Van Tuyn J, Pijnappels D, Haeck M, Knaän-Shanzer S, Scherjon S, Goumans M, . Potential of human mesenchymal stem cells to differentiate into cardio myocytes depends on donor age and donor tissue. Circulation 2008;118(abstr):S421.
   Google Scholar
• Losordo DW, Schatz RA, White CJ, Udelson JE, Veereshwarayya V, Durgin M, . Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina. A phase I/IIa double-blind randomized controlled trial. Circulation 2007;115:3165–72.
   PubMed Web of Science ®Google Scholar
• Kawamoto A, Iwasaki H, Kusano K, Murayama T, Oyamada A, Silver M, . CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocar-dial infarction compared with total mononuclear cells. Circulation 2006;114:2163–9.
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, . Bone marrow cells regenerate infarcted myocardium. Nature 2001;410:701–5.
   PubMed Web of Science ®Google Scholar
• Sondergaard CS, Bonde J, Dagnæs-Hansen F, Nielsen JM, Zachar V, Holm M, . Minimal engraftment of human CD34+ cells mobilized by healthy donors in the infarcted heart of athymic nude mice. Stem Cells Dev 2008(in press).
   Google Scholar